Amexdrug Current Cash

The latest current cash for AXRX is $58K as of March 2026. That compares with $38K in the prior-year period — up 51.5% year over year. Investors often review this figure alongside Amexdrug's historical trend and sector peers before judging valuation or financial health.

Over the past year, AXRX's current cash moved from $38K to $58K — a 51.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Amexdrug's operating scale or balance-sheet position.

A current cash figure of $58K for AXRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AXRX's current cash ($58K), review year-over-year change from $38K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.